Brahmi: Plant Profile, Traditional Use, and Modern Research
The 30-second answer
Brahmi is the aerial part of Bacopa monnieri, a creeping, semi-aquatic plant in the Plantaginaceae family. It has been used in Ayurvedic medicine for over 2,500 years and is classified as a Medhya Rasayana – a traditional class of herbs associated with intellect and mental function. Modern research has investigated its effects on memory, attention, and cognitive performance in roughly a dozen randomised controlled trials. Important: another plant, Centella asiatica (Gotu Kola), is also sometimes called brahmi in southern Indian traditions – this page is about Bacopa monnieri.
Key facts
- Plant family: Plantaginaceae (formerly Scrophulariaceae)
- Parts used: aerial parts (whole herb above ground, including stems and leaves)
- Active compounds: bacosides A and B, bacopasides, alkaloids (brahmine, herpestine)
- Habitat: marshy, semi-aquatic; grows in standing water across India and Southeast Asia
- Traditional context: Medhya Rasayana (intellect-supporting rejuvenative)
- Doses studied: 300–600mg standardised extract, daily, typically for 8–12 weeks
- Should not use: pregnancy, breastfeeding, slow heart rate or bradycardia, stomach ulcers without GP guidance
What is brahmi? (and which brahmi)
The first thing to clear up is the name. Two completely different plants are traditionally called brahmi. The canonical “brahmi” in modern Ayurveda and almost all clinical research is Bacopa monnieri – a small, creeping, semi-aquatic herb with thick fleshy leaves and tiny white or pale-violet flowers. The other plant sometimes called brahmi (especially in southern Indian traditions) is Centella asiatica, more commonly known in the West as Gotu Kola. The two have similar traditional applications but distinct phytochemistry and clinical evidence bases. Throughout this page, brahmi refers to Bacopa monnieri.
Bacopa monnieri grows naturally in marshy ground, ditches, and along the edges of paddy fields across India, Sri Lanka, Southeast Asia, and parts of Australia and the southern United States. The plant rarely grows more than a few centimetres above the water line, which is why it is sometimes harvested by hand from semi-flooded fields.
The Sanskrit name brahmi comes from Brahma, the creative principle in Hindu cosmology associated with intellect and consciousness – reflecting the herb’s long classification as a tonic for the mind.
The whole aerial part is harvested for medicinal use.
Which parts of the plant are used?
Almost all medicinal use of brahmi involves the aerial parts – the entire above-ground portion of the plant, including stems, leaves, and small flowers. These are typically harvested when the plant is in flower (for highest active-compound content), then washed, dried, and either ground or extracted.
The roots are not generally used medicinally. Most clinical trials use either dried whole-herb powder or a standardised extract characterised by its bacoside content.
Did you know?
In ancient India, students preparing for memorisation of long Vedic texts were traditionally given brahmi as part of their daily routine. The herb’s reputation as an aid to long-form memory work is older than most written records.
Active compounds
Brahmi’s primary active compounds are the bacosides – a family of triterpenoid saponins found almost exclusively in Bacopa monnieri. Bacosides A and B are the principal bioactive constituents, alongside related bacopasides. The herb also contains alkaloids including brahmine and herpestine, and a range of secondary triterpenoid compounds.
Modern standardised extracts are typically characterised by their total bacoside content, expressed as a percentage by weight – commonly 20%, 50%, or in some specialised extracts up to 55% bacosides. Most positive clinical trials have used extracts standardised to at least 20% bacosides.
2,500+
Years of documented use
12+
Randomised cognitive trials
8–12
Weeks for measurable effects
A brief history of brahmi
Brahmi has one of the most consistent traditional applications of any Ayurvedic herb – associated continuously with mental function from the earliest texts to modern research.
c. 600 BCE – 600 CE
Classical Ayurvedic period
Brahmi appears in the Charaka Samhita (compiled c. 200 BCE – 200 CE) within the Medhya Rasayana category – a small group of herbs traditionally associated with intellect, memory, and clarity. The Sushruta Samhita listed similar applications and described topical uses for skin and hair.
c. 600 – 1700 CE
Medieval Ayurvedic period
The 16th-century Bhavaprakasha described brahmi alongside other medhya herbs and detailed traditional preparations using ghee and milk to enhance absorption. Brahmi was a standard ingredient in monastic and scholarly diets across South Asia.
1700s – 1947
Colonial era
British colonial physicians and botanists working in India catalogued Bacopa monnieri but – as with most Ayurvedic herbs – did not investigate it pharmacologically. The plant was noted in colonial flora records as a marshland weed with traditional uses.
1950s – 1990s
Chemistry and early research
The bacosides were isolated and characterised in the 1960s by Indian chemists at the Central Drug Research Institute in Lucknow. Early animal studies in the 1980s investigated effects on memory and learning in standardised behavioural tests, building the case for human trials.
2000s – present
Modern revival
The first major human trials were published from the late 1990s onward, with Stough et al.’s 2001 study in Psychopharmacology marking a turning point in the Western literature. Brahmi has since become one of the more frequently studied herbs in the cognitive research space, and a recurring ingredient in nootropic supplement formulations.
Traditional Ayurvedic context
In classical Ayurveda, brahmi is described as bitter, astringent, light, and cooling. It primarily balances pitta and kapha doshas. It belongs to the Medhya Rasayana category – a small classical grouping that also includes Mandukaparni (Centella asiatica), Yashtimadhu (licorice), and Shankhpushpi.
Medhya Rasayana are those which support intellect, retention, and the clear functioning of the mind.
— traditional Ayurvedic categorisation, derived from Charaka Samhita, Chikitsa Sthana
Traditional descriptions of brahmi’s role include use in medhya (intellect-related) preparations, daily rasayana use as a tonic, traditional pairings with milk, ghee, or honey for absorption, and topical applications for the scalp described in classical texts. These descriptions reflect classical Ayurvedic categorisation and historical use; they do not constitute claims about the effects of any modern food supplement.
Modern research
Brahmi has one of the better-developed clinical evidence bases among cognitive-associated Ayurvedic herbs. Trials are still typically small (40–100 participants) and short (8–12 weeks), but the consistency of measured outcomes is reasonable. Most studies use standardised extracts characterised by bacoside content. The studies described below are reported here as published research; the descriptions are not statements about the effects of any r‑veda product.
| Topic | Study | Participants | Duration |
|---|---|---|---|
| Memory | Stough 2001 | 76 | 12 weeks |
| Verbal recall | Roodenrys 2002 | 76 | 12 weeks |
| Cognition (elderly) | Calabrese 2008 | 54 | 12 weeks |
| Attention | Nathan 2001 | 38 | acute |
| Cognition (review) | Pase 2012 | Multiple trials | – |
| Cognition (meta-analysis) | Kongkeaw 2014 | 9 trials pooled | – |
| Anxiety / mood | Calabrese 2008 (secondary) | 54 | 12 weeks |
Tap a column heading to sort. Scroll for the full table on small screens.
See full study details
Memory and learning research
Stough et al. (2001, Psychopharmacology) studied 76 adults given 300mg of standardised brahmi extract (BacoMind, 50% bacosides) daily for 12 weeks. Endpoints included tests of memory acquisition, retention, and information processing. Roodenrys et al. (2002, Neuropsychopharmacology) ran a parallel-group trial in 76 healthy adults with verbal recall as primary endpoint. Both trials measured changes after 12 weeks of consistent use.
Cognitive function in older adults
Calabrese et al. (2008, Journal of Alternative and Complementary Medicine) studied 54 adults aged 65 and older given 300mg daily of a Bacopa standardised extract for 12 weeks. Cognitive performance, anxiety, and depression scores were measured.
Attention and acute effects
Nathan et al. (2001, Human Psychopharmacology) studied 38 healthy adults in an acute single-dose trial measuring attention, learning, and memory tasks.
Reviews and meta-analyses
Pase et al. (2012, Journal of Alternative and Complementary Medicine) systematically reviewed the human evidence on Bacopa and cognition. Kongkeaw et al. (2014, Journal of Ethnopharmacology) pooled nine RCTs in a meta-analysis, finding consistent direction of effect across cognitive endpoints, particularly on tests of memory acquisition. Morgan and Stevens (2010) provided an earlier review of the evidence base.
How to read this evidence base
Brahmi’s clinical evidence base is more focused than ashwagandha’s – most trials measure cognitive endpoints, with relatively little research on other applications. Most trials use standardised extracts at 300–600mg/day for at least 8 weeks; acute single-dose studies generally show smaller effects than longer-term use. As with most Ayurvedic herbs, larger independent trials in Western populations remain limited.
Forms and preparations
Brahmi has historically been consumed in several forms.
- Churna–dried whole-herb powder, traditionally taken with milk or ghee
- Brahmi ghrita–herb infused into clarified butter, used in classical preparations
- Decoction (kashayam)–simmered in water as a traditional liquid preparation
- Tincture–alcoholic extract
- Capsule–standardised extract; the most dose-accurate option for daily use and the form used in most clinical trials
Doses used in clinical research range from 300mg to 600mg of standardised extract (typically 20%–50% bacosides) per day, taken with food, over study periods of 8 to 12 weeks. These figures describe what has been studied in research – they are not dietary recommendations.
Suitability and cautions
Brahmi is generally well tolerated, but a few cautions apply:
- Pregnant or breastfeeding women should avoid brahmi.
- People with bradycardia or other slow heart-rate conditions should consult a GP before use; brahmi has been associated with cardiac slowing in some studies.
- People with thyroid conditions should consult a GP before use, as brahmi may interact with thyroid medication.
- People with stomach ulcers or significant gastrointestinal sensitivity should be aware that brahmi may cause mild gastric upset, particularly when taken without food.
- People taking sedatives, anti-anxiety medication, or anticonvulsants should consult a GP before use.
As with any food supplement, stop use and consult a healthcare professional if you experience any adverse effects.
